CADTH | Evidence Driven
CADTH | Evidence Driven

Sodium-glucose Cotransporter-2 Inhibitors for Chronic Kidney Disease

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1634-000
Effective finish date:

Question

  1. What literature describes the potential clinical benefits and harms of sodium-glucose cotransporter-2 inhibitors in adults with chronic kidney disease?

Key Message

We found 5 systematic reviews and 36 randomized controlled trials about the potential clinical benefits of sodium-glucose cotransporter-2 inhibitors in adults with chronic kidney disease.

Files

Sodium-glucose Cotransporter-2 Inhibitors for Chronic Kidney Disease View PDF
Last Updated : September 27, 2022